These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3106123)

  • 1. Effect of growth hormone releasing hormone on growth hormone secretion in type 2 (non-insulin-dependent) diabetes mellitus.
    Pietschmann P; Schernthaner G
    Diabetologia; 1987 Jan; 30(1):13-5. PubMed ID: 3106123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exaggerated growth hormone response to growth hormone-releasing hormone in type I diabetes mellitus.
    Krassowski J; Felber JP; Rogala H; Jeske W; Zgliczynski S
    Acta Endocrinol (Copenh); 1988 Feb; 117(2):225-9. PubMed ID: 3132790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II Diabetic patients.
    Giustina A; Bresciani E; Tassi C; Girelli A; Valentini U
    Metabolism; 1994 Jul; 43(7):893-8. PubMed ID: 8028515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
    Ismail IS; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone releasing hormone on growth hormone, prostaglandin E2 and insulin in non-insulin-dependent diabetic patients.
    Koev D; Zacharieva S; Popova J; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):137-40. PubMed ID: 8740245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blunted GH response to growth hormone-releasing hormone (GHRH) alone or combined with arginine in non-insulin-dependent diabetes mellitus.
    Martina V; Bruno G; Tagliabue M; Bertaina S; Maccario M; Grottoli S; Procopio M; Ozzello A; Camanni F
    Horm Metab Res; 1995 Jan; 27(1):26-30. PubMed ID: 7729789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired growth hormone response to human pancreatic growth hormone releasing factor [GRF(1-44)] in type 2 (non-insulin-dependent) diabetes.
    Richards NT; Wood SM; Christofides ND; Bhuttacharji SC; Bloom SR
    Diabetologia; 1984 Nov; 27(5):529-34. PubMed ID: 6439589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone response to growth hormone releasing factor in diabetic men.
    Kopelman PG; Mason AC; Noonan K; Monson JP
    Clin Endocrinol (Oxf); 1988 Jan; 28(1):33-8. PubMed ID: 3139333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence for increased growth hormone responses to growth hormone-releasing hormone in patients with diabetic retinopathy.
    Pietschmann P; Schernthaner G; Prskavec F; Gisinger C; Freyler H
    Diabetes; 1987 Feb; 36(2):159-62. PubMed ID: 3100367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.
    Micić D; Macut D; Popović V; Kendereski A; Sumarac-Dumanović M; Zorić S; Dieguez C; Casanueva FF
    Metabolism; 1999 Apr; 48(4):525-30. PubMed ID: 10206449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity.
    Ghigo E; Procopio M; Boffano GM; Arvat E; Valente F; Maccario M; Mazza E; Camanni F
    Metabolism; 1992 May; 41(5):560-3. PubMed ID: 1588839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The response of obese subjects to continuous infusion of human pancreatic growth hormone-releasing factor 1-44.
    Davies RR; Turner SJ; Cook D; Alberti KG; Johnston DG
    Clin Endocrinol (Oxf); 1985 Nov; 23(5):521-5. PubMed ID: 3936648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone response to low dose intravenous injections of growth hormone releasing factor in obese and normal weight women.
    Kopelman PG; Noonan K
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):157-64. PubMed ID: 2871950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dietary restriction and repeated growth hormone-releasing factor injections on growth hormone response to growth hormone-releasing factor in obese subjects.
    Csizmadi I; Brazeau P; Serri O
    Metabolism; 1989 Oct; 38(10):1016-21. PubMed ID: 2507875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction.
    Williams T; Berelowitz M; Joffe SN; Thorner MO; Rivier J; Vale W; Frohman LA
    N Engl J Med; 1984 Nov; 311(22):1403-7. PubMed ID: 6436706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of coadministered growth hormone (GH)-releasing hormone and GH-releasing hexapeptide on maladaptive aspects of obesity in Zucker rats.
    Bercu BB; Yang SW; Masuda R; Hu CS; Walker RF
    Endocrinology; 1992 Dec; 131(6):2800-4. PubMed ID: 1446617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity.
    Kopelman PG; Noonan K; Goulton R; Forrest AJ
    Clin Endocrinol (Oxf); 1985 Jul; 23(1):87-94. PubMed ID: 2863016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
    Cordido F; Peñalva A; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.